Tuesday, October 04, 2016

B - Ghostwriting in drug marketing

Matheson A. Ghostwriting: the importance of definition and its place in contemporary drug marketing. BMJ 2016;354:i4578
(doi: 10.1136/bmj.i4578)

During the past decade, the pharmaceutical publications industry has campaigned to persuade medicine, journals, ethicists, and the media that it is opposed to ghostwriting. Yet ghostwriting remains widespread in industry financed medical journal literature. The author describes how the pharmaceutical publications industry seeks to legitimise ghostwriting by changing its definition while deflecting attention from wider marketing practices in academic publishing.
http://www.bmj.com/content/354/bmj.i4578

No comments: